|
⚲
|
| Keyboard |
| OrbiMed Capital GP II LLC
✚
|
|
|---|---|
| CIK # | 0001281668 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001281668] | |
| 4 | [0001281668] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Isaly Samuel D | |
| Acceleron Pharma Inc | |
| OrbiMed Capital GP II LLC | |
| OrbiMed Advisors LLC | |
| Supernus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acceleron Pharma Inc XLRN
Series D Convertible Preferred · derivative
|
2013-09-24 | Conversion | 23,442 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 1,127,346 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 38,924 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 422,101 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 175,419 | ||
|
Acceleron Pharma Inc XLRN
Series F Convertible Preferred · derivative
|
2013-09-24 | Conversion | 14,574 | ||
|
Acceleron Pharma Inc XLRN
Series B Convertible Preferred Stock · derivative
|
2013-09-24 | Conversion | 1,127,346 | ||
|
Acceleron Pharma Inc XLRN
Series B Convertible Preferred Stock · derivative
|
2013-09-24 | Conversion | 422,101 | ||
|
Acceleron Pharma Inc XLRN
Series C Convertible Preferred · derivative
|
2013-09-24 | Conversion | 175,419 | ||
|
Acceleron Pharma Inc XLRN
Series C Convertible Preferred Stock · derivative
|
2013-09-24 | Conversion | 65,680 | ||
|
Acceleron Pharma Inc XLRN
Series F Convertible Preferred · derivative
|
2013-09-24 | Conversion | 38,924 | ||
|
Acceleron Pharma Inc XLRN
Series E Convertible Preferred · derivative
|
2013-09-24 | Conversion | 8,466 | ||
|
Acceleron Pharma Inc XLRN
Series E Convertible Preferred · derivative
|
2013-09-24 | Conversion | 22,612 | ||
|
Acceleron Pharma Inc XLRN
Series E Convertible Preferred Stock · derivative
|
2013-09-24 | Conversion | 31,113 | ||
|
Acceleron Pharma Inc XLRN
Series E Convertible Preferred · derivative
|
2013-09-24 | Conversion | 83,097 | ||
|
Acceleron Pharma Inc XLRN
Series D Convertible Preferred Stock · derivative
|
2013-09-24 | Conversion | 8,777 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 23,442 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 8,777 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 133,930 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 50,145 | ||
| showing 20 of 39 most recent transactions | |||||